SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-046063
Filing Date
2022-04-14
Accepted
2022-04-14 16:35:46
Documents
12
Period of Report
2022-04-14
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2212610d1_8k.htm   iXBRL 8-K 26163
  Complete submission text file 0001104659-22-046063.txt   200466

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nviv-20220414.xsd EX-101.SCH 3063
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE nviv-20220414_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nviv-20220414_pre.xml EX-101.PRE 22615
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2212610d1_8k_htm.xml XML 3622
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37350 | Film No.: 22827732
SIC: 3841 Surgical & Medical Instruments & Apparatus